AstraZeneca vaccine promises with seniors and trial results by Christmas – Politics – News


Data, published today, Thursday, showed that the vaccine that AstraZeneca and the University of Oxford are working on produced has achieved a strong immune response in the elderly, and researchers expect to publish the results of the last stage of tests by Christmas..

The data indicate that the vaccine has provided those over the age of 70, who are the most vulnerable group to disease and death from Covid-19, strong immunity from the disease. A summary of this data was published last month, but was published in full in the (Lancet) medical journal on Thursday.

Maheshi Ramasamy, a consultant and co-head of the research team at the Oxford Vaccine Group, said he hoped the vaccine would help protect some of the most vulnerable groups to the disease, but stressed the need for more research to be done before making sure..

Andrew Pollard, director of the Oxford Vaccine Group, said that the results of these trials will be known by Christmas and that it is too early to know how successful the vaccine will be in preventing COVID-19 infection..

The Oxford / AstraZeneca vaccine was one of the most prominent vaccines being developed as part of the international efforts to combat the Corona virus.

However, Pfizer and Biontech Pharmaceuticals and Moderna Company have made progress in the last ten days and have published data on trials of the last phase of two vaccines that show that their effectiveness exceeds 90%..

Google Newsstand

Follow our latest local and sports news, and the latest political and economic developments via Google news




Please enter your comment!
Please enter your name here